| Literature DB >> 34297546 |
Hossein Sanjari Moghaddam1, Maryam Mobarak Abadi1, Mahsa Dolatshahi1, Sasan Bayani Ershadi1, Fatemeh Abbasi-Feijani2, Sahar Rezaei1, Giulia Cattarinussi3, Mohammad Hadi Aarabi3.
Abstract
Methamphetamine (MA) can cross the placenta in pregnant women and cause placental abruption and developmental alterations in offspring. Previous studies have found prenatal MA exposure effects on the social and cognitive performance of children. Recent studies reported some alterations in structural and functional magnetic resonance imaging (MRI) of prenatal MA-exposed offspring. In this study, we aimed to investigate the effect of prenatal MA exposure on brain development using recently published structural, metabolic, and functional MRI studies. According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we searched PubMed and SCOPUS databases for articles that used each brain imaging modality in prenatal MA-exposed children. Seventeen studies were included in this study. We investigated brain imaging alterations using 17 articles with four different modalities, including structural MRI, diffusion tensor imaging (DTI), magnetic resonance spectroscopy (MRS), and functional MRI (fMRI). The participants' age range was from infancy to 15 years. Our findings demonstrated that prenatal MA exposure is associated with macrostructural, microstructural, metabolic, and functional deficits in both cortical and subcortical areas. However, the most affected regions were the striatum, frontal lobe, thalamus and the limbic system, and white matter (WM) fibers connecting these regions. The findings from our study might have valuable implications for targeted treatment of neurocognitive and behavioral deficits in children with prenatal MA exposure. Even so, our results should be interpreted cautiously due to the heterogeneity of the included studies in terms of study populations and methods of analysis.Entities:
Keywords: MRI; Prenatal methamphetamine; neurodevelopmental disorder; neuroimaging
Mesh:
Substances:
Year: 2021 PMID: 34297546 PMCID: PMC8763371 DOI: 10.1021/acschemneuro.1c00213
Source DB: PubMed Journal: ACS Chem Neurosci ISSN: 1948-7193 Impact factor: 4.418
Figure 1PRISMA flow diagram for neuroimaging studies in prenatal methamphetamine (MA) exposure.
Overview of Reviewed Articles: Demographic Profile of Offspring and the Related Maternal Profile by Imaging Modalitya
| | offspring profile | maternal profile | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| drug use during pregnancy | |||||||||||||||
| ref | study groups | years of
educ. | depr. | MA | alc | nic/tob | marij | matched in | differed in | ||||||
| Structural MRI Studies | |||||||||||||||
| 1 | ( | MA-exposed | 13/4 | 6.9 ± 3.5 | – | – | – | – | – | – | – | – | – | age, gender distrib, both recruited from the same population of predominately lower and middle soc/ec status | – |
| unexposed | 15/6 | 7.8 ± 3.2 | |||||||||||||
| (inclusion based on DSM-IV criteria for at least two-thirds of the pregnancy; exclusion criteria: GA of less than 37 weeks, developmental delay, impaired growth, seizure disorders or ADHD, significant maternal illness during gestation, dependence on other illicit drugs (except Meth) or alcohol) | (years) | ||||||||||||||
| 2 | ( | MA-exposed | 21/12 | 9.66 ± 1.85 | – | – | – | – | – | 3/3 of interviewd mothers reported use of MA/alc during pregnancy, the rest suffered social/legal problems | 18/21 with alc exposure, 3/3 of interviewd mothers reported use of MA/alc during pregnancy, the rest suffered social/legal problems | – | – | age, gender distrib, handedness, soc/ec status (family annual income) | FSIQ ( |
| alcohol-exposed | 13/8 | 11.15 ± 2.34 | |||||||||||||
| unexposed | 27/11 | 10.15 ± 2.90 | |||||||||||||
| (exclusion criteria: children with prenatal exposure to cocaine or other opiates, who were <5 years of age, who had an IQ < 70, or had a physical, psychiatric, or developmental disability, or any other potential known causes of mental deficiency) | (years) | ||||||||||||||
| 3 | ( | MA-exposed | 20/11 | 45.76 ± 6.78 | 38.55 ± 1.85 | – | 25.5 ± 6.7 | 10 | 6.81 ± 7.46 | 19/26 used MA | – | 19/20 used tob | – | age, gender
distrib, handedness, | between tob-exposed
and tob-unexposed groups: prenatal exposure to MA ( |
| not MA-exposed | 15/8 | 47.26 ± 7.88 | 39.20 ± 1.15 | 22.3 ± 3.0 | 8 | 8.76 ± 6.45 | 1/9 used MA | 7/15 used tob | |||||||
| tobacco-exposed | 26/19 | 46.43 ± 6.85 | 38.58 ± 1.65 | 24.2 ± 5.5 | 15 | 6.92 ± 6.97 | |||||||||
| not tobacco-exposed | 9/9 | 46.33 ± 8.59 | 39.56 ± 1.24 | 23.9 ± 6.2 | 3 (number of participants with less than a high school education) | 9.74 ± 7.11 | |||||||||
| (maternal exclusion criteria: not speaking English; <18 years of age; used opiates, LSD, PCP, or cocaine only during pregnancy; severe retardation, emotional, cognitive, or past psychosis; infant exclusions: critically ill and unlikely to survive; multiple gestation; life-threatening congenital anomaly; chromosomal abnormality associated with mental or neurological deficiency; overt clinical evidence of an intrauterine infection, or sibling previously enrolled in the study) | (months) | ||||||||||||||
| 4 | ( | MA-exposed | 18/10 | 6.45 ± 0.42 | – | 51.75 ± 1.72 | – | 8.88 ± 1.32 | – | – | 3 mothers in the MA-exposed group | – | – | age, gender distrib, soc/ec profile, gestation, birth circumstances, income, and schooling | education ( |
| unexposed | 18/8 | 6.51 ± 0.33 | 51.99 ± 2.41 | 10.25 ± 2.32 | |||||||||||
| (exclusion criteria: fetal anomalies; history of epilepsy, diabetes, head injury, or prematurity); three of the mothers in the MA-exposed group also used alcohol; mothers/caregivers stated that no other drugs (e.g., cocaine, heroin) were used besides MA during the pregnancy; none of the mothers of the controls used alcohol or illicit drugs | (years) | (current | |||||||||||||
| 5 | ( | MA-exposed | 18/6 | 40.5 ± 2.1 | 37.6 ± 2.7 | 32.9 ± 1.9 | 27.0 ± 4.2 | 9.3 ± 1.4 | – | – | 10/18: 0.2 ± 0.4 oz AA/day | 18/18: 6.5 ± 4.5 cig/day | 10/18: 5.8 ± 8.4 days/month | age, gender
distrib, maternal age, | abusing tob
( |
| unexposed | 21/12 | 41.6 ± 1.9 | 39.1 ± 2.0 | 33.3 ± 2.0 | 26.7 ± 5.9 | 10.5 ± 1.4 | 1/21: 0.0 ± 0.0 oz AA/day | 13/21: 3.5 ± 3.4 cig/day | 2/21: 0.0 ± 0.1 days/month | ||||||
| (the control group, recruited from the same community, comprising infants whose mothers abstained from alcohol and other drugs of abuse or who consumed no more than 2 drinks on 2 or fewer occasions during pregnancy; exclusion criteria for mothers were <18 years of age, HIV positive, treatment for medical conditions such as hypertension, epilepsy, diabetes or heart disease, and multiple pregnancies; infant exclusion criteria were neural tube defects, major chromosomal anomalies, very low birth weight (<1200 g), gestational age <30 weeks, and seizures) | ( | ||||||||||||||
| 6 | ( | MA-exposed | 17/10 | 6.9 ± 0.4 | 9 ± 1.3 | 4/17 consuming alc | 13/17 smoking | age, gender distrib, maternal educ | cig smoking
( | ||||||
| 8.0 ± 0.5 | |||||||||||||||
| unexposed | 16/7 | 6.5 ± 0.3 | 10 ± 2.2 | 6/16 smoking | |||||||||||
| 8.3 ± 0.4 | |||||||||||||||
| (exclusion: history of genetic anomalies, neurological disorders, head injury, or prematurity) | (years) | ||||||||||||||
| DTI Studies | |||||||||||||||
| 1 | ( | MA-exposed | 29/20 | 48.4 ± 1.4 | 38.8 ± 0.3 | 50.5 ± 0.3 | 25.1 ± 1.1 | 12.7 ± 0.4 | – | 2.5 ± 0.2 trimesters, 57.9 ± 31.0 g (data for 16 mothers) | 15.3 ± 9.8 drinks (data for 15 mothers) | 88 ± 26 packs (data for 20 mothers) | 18.2 ± 17.0 joints (data for 16 mothers) | age, gender
distrib, | lower
maternal/caretaker
educ, index of social position ( |
| unexposed | 37/19 | 47.7 ± 1.2 | 39.2 ± 0.2 | 50.5 ± 0.2 | 29.9 ± 1.3 | 14.2 ± 0.5 | NA | 0.1 ± 0.01 drinks | 25 ± 16 packs | 0.8 ± 0.8 joints | |||||
| (exclusion criteria: any congenital, genetic, or other major neurological disorders, prematurity, FTT within the first year of life, overt TORCH infection at birth, mother or legal guardian who were non-English speaking, low cognitive functioning (estimated verbal IQ < 80), HIV-1 during pregnancy, a history of comorbid psychiatric illness or a major medical condition compromising brain development, a history of DSM-IV dependence on alcohol or other drugs except nicotine and MA during pregnancy) | (months) | (current | |||||||||||||
| 2 | ( | MA-exposed | 21/13 | 9.76 ± 1.84 | – | – | – | 15.13 ± 2.29 | – | – | – | 12/21 exposed, 1/21 not exposed, 8/21 unknown | – | age, gender distrib, handedness, parental educ, parental IQ, family income, trails B performance, number of scan averages | prorated full-scale
IQ ( |
| unexposed | 27/11 | 10.30 ± 3.35 | 16.33 ± 2.87 | 27/27 not exposed | |||||||||||
| (exclusion criteria: age younger than 5 years, IQ < 70, head injury with loss of consciousness for >20 min, other causes of mental deficiency like chromosomal syndromes, any physical or psychiatric illness, or developmental disability preventing completion of the scanning or neuropsychological testing sessions) | (years) | ||||||||||||||
| 3 | ( | MA-exposed | 17/9 | 6.71 ± 0.40 | – | 51.79 ± 1.76 | – | 8.81 ± 1.33 | – | – | 3/17 consuming alc | 14/17 smokers | – | age, gender
distrib, current weight, length, and | smoking ( |
| unexposed | 15/5 | 6.83 ± 0.39 | 51.86 ± 1.79 | 9.93 ± 2.30 | 6/15 smokers | ||||||||||
| (exclusion: history of genetic anomalies, neurological disorders, head injury, or prematurity) | (years) | (current | |||||||||||||
| 4 | ( | MA/tobacco-exposed | 36/19 | 57.21 ± 8.05 | 39.04 ± 0.28 | 34.07 ± 0.22 | 28.36 ± 1.12 | 11.71 ± 0.32 | BDI: 11.94 ± 1.71 | – | 15/36 (0.56 ± 0.13 trimesters, 7.92 ± 2.94 drinks) | 35/36 (2.28 ± 0.15 trimesters, 1364 ± 341 cig) | 15/36 (0.78 ± 0.18 trimesters, 36.71 ± 31.97 cig) | age, | sex ( |
| EDPS: 5.44 ± 0.68 | |||||||||||||||
| tobacco-exposed | 32/21 | 56.44 ± 6.94 | 37.47 ± 0.69 | 32.85 ± 0.74 | 27.50 ± 0.91 | 12.50 ± 0.30 | BDI: 9.91 ± 1.40 | 10/32 (0.34 ± 0.09 trimesters/2.78 ± 0.96 drinks) | 32/32 (1.78 ± 0.16 trimesters/2717 ± 407 cig) | 7/32 (0.31 ± 0.11 trimesters/32.41 ± 18.84 cig) | |||||
| EPDS: 7.40 ± 0.93 | |||||||||||||||
| unexposed | 71/27 | 38.39 ± 0.36 | 33.90 ± 0.36 | 28.89 ± 0.68 | 14.28 ± 0.30 | BDI: 7.48 ± 0.91 | 13/71 (0.27 ± 0.07 trimesters/0.83 ± 0.38 drinks) | 0/71 | 1/71 (0.01 ± 0.01 trimesters/0.03 ± 0.03 cig) | ||||||
| EPDS: 7.85 ± 1.07 | |||||||||||||||
| (exclusion criteria: infants with excessive maternal alcohol use, maternal polysubstance or cocaine dependency, human immunodeficiency virus-infected mother receiving zidovudine or prolonged neonatal intensive care) | (weeks) | ||||||||||||||
| 5 | ( | MA-exposed | 11/5 | 40.6 ± 2.1 | 37.3 ± 3.0 | – | 27.2 ± 3.9 | 9.4 ± 1.2 | – | 7.1 ± 3.5 days/month | 0.2 ± 0.4 oz AA/day | 6.5 ± 5.4 cig/day | 4.4 ± 9.6 days/month | age, gender
distrib, | maternal educ
( |
| unexposed | 12/7 | 41.6 ± 1.9 | 39.0 ± 1.7 | 25.1 ± 5.4 | 10.6 ± 1.1 | NA | 0.0 ± 0.0 oz AA/day | 3.3 ± 2.8 cig/day | 0.0 ± 0.1 days/month | ||||||
| ( | |||||||||||||||
| 6 | ( | MA-exposed | 11/5 | 40.6 ± 2.1 | 37.3 ± 3.0 | 27.2 ± 3.9 | 9.4 ± 1.2 | 7.1 ± 3.5 days/month | 0.2 ± 0.4 oz AA/day | 6.5 ± 5.4 cig/day | 4.4 ± 9.6 days/month | age, gender
distrib, | maternal educ
( | ||
| unexposed | 12/7 | 41.6 ± 1.9 | 39.0 ± 1.7 | 25.1 ± 5.4 | 10.6 ± 1.1 | NA | 0.0 ± 0.0 oz AA/day | 3.3 ± 2.8 cig/day | 0.0 ± 0.1 days/month | ||||||
| (exclusion: maternal age <18 years, multiple gestation pregnancy, HIV positive, or receiving treatment for medical conditions, including hypertension, heart disease, epilepsy, or diabetes; infants with neural tube defects, seizures, and chromosomal abnormalities) | ( | ||||||||||||||
| MRS Studies | |||||||||||||||
| 1 | ( | MA-exposed | 12/? | 8.1 ± 0.8 | – | – | – | – | – | 2/12 reported “trying” cocaine, occasionally | 4/12 reported alc use (all <0.5 oz. of AA/day) | 6/12: 17 ± 8 cig/day | – | – | – |
| unexposed | 14/? | 7.3 ± 1.1 | 0/14 exposed | 1/14 exposed | |||||||||||
| (exclusion criteria: preterm infants, developmental delay, impaired growth, seizure disorders, or ADHD, major maternal illness or requiring medication for a chronic illness, other illicit drug abuse) | (years) | ||||||||||||||
| 2 | ( | MA-exposed | 49/30 | 46.90 ± 1.07 | 38.74 ± 0.23 | 50.37 ± 0.21 | 24.53 ± 0.99 | 12.19 ± 0.30 | BDI: 10.41 ± 2.05 | 2.42 ± 0.14 trimesters | 0.85 ± 0.21 trimesters | 2.05 ± 0.21 trimesters | 1.00 ± 0.22 trimesters | age, gender
distrib, current height, current weight, current | alc use ( |
| unexposed | 49/27 | 45.17 ± 0.99 | 39.47 ± 0.18 | 50.63 ± 0.18 | 26.06 ± 0.96 | 12.92 ± 0.29 | BDI: 10.53 ± 1.75 | NA | 0.21 ± 0.08 trimesters | 0.67 ± 0.17 trimesters | 0.12 ± 0.07 trimesters | ||||
| (exclusion criteria were any congenital, genetic, or other major neurological disorders, prematurity, FTT within the first year of life, overt TORCH infection at birth, mothers with age <17 years, non-English speaking, low cognitive functioning (estimated verbal IQ < 80) or institutionalized for retardation, HIV-1 during pregnancy, a history of comorbid psychiatric illness or a major medical condition compromising brain development, a history of drug dependence during pregnancy except for MA and nicotine) | (months) | (current | (in the MA-exposed group, light alc use, i.e., less than 1 drink/day, was allowed) | (in the MA-exposed group, light marij usewas allowed) | |||||||||||
| fMRI Studies | |||||||||||||||
| 1 | ( | MA-exposed | 14/10 | 9.5 ± 1.91 | – | – | – | 15.93 ± 2.84 | – | – | 12/14 prenatal alc exposure (comparable to alc-exposed groups) | 6/14 exposed, 7/14 unknown exposure | – | age, gender distrib, handedness, parental educ, parental IQ, family annual income | FSIQ ( |
| unexposed | 20/9 | 10.5 ± 2.56 | 15.80 ± 3.19 | 0/20 exposed to nic | |||||||||||
| (exclusion criteria: concomitant diagnosis of FAS or PFAS (severe manifestations of heavy alcohol exposure), known prenatal exposure to cocaine or opiates, age less than 7 years, IQ less than 70, head injury with loss of consciousness over 20 min, physical, psychiatric, or developmental disability, other known causes of mental deficiency like chromosomal anomalies, major maternal illness compromising brain development) | |||||||||||||||
| 2 | ( | MA-exposed | 19/11 | 9.16 ± 1.83 | – | – | – | – | – | – | – | – | – | age, gender distrib | FSIQ ( |
| unexposed | 18/9 | 10.28 ± 2.61 | |||||||||||||
| (exclusion criteria: known prenatal exposure to cocaine or opiates, age less than 7 years, IQ less than 70, head injury with loss of consciousness over 20 min, physical, psychiatric, or developmental disability, other known causes of mental deficiency like chromosomal anomalies, major maternal illness compromising brain development, performing below 1.5 standard deviations from the mean performance of their group on the N-Back task, or poor fMRI data quality | |||||||||||||||
| 3 | ( | MA-exposed | 19/11 | 9.16 ± 1.83 | – | – | – | – | – | – | – | – | – | age, gender distrib | FSIQ ( |
| unexposed | 18/9 | 10.28 ± 2.61 | |||||||||||||
| (exclusion criteria: known prenatal exposure to cocaine or opiates, age less than 7 years, IQ less than 70, head injury with loss of consciousness over 20 min, physical, psychiatric, or developmental disability, other known causes of mental deficiency like chromosomal anomalies, major maternal illness compromising brain development, performing below 1.5 standard deviations from the mean performance of their group on the N-Back task, or poor fMRI data quality | |||||||||||||||
Abbreviations: MA, methamphetamine; MRI, magnetic resonance imaging; DTI, diffusion tensor imaging; MRS, magnetic resonance imaging; fMRI, functional MRI; HRT, hit response time; ISI, interstimulus interval; EPDS, Edinburgh postnatal depression scale; BDI, Beck depression inventory; FTT, failure to thrive; ADHD, attention deficit hyperactivity disorder; FSIQ, full scale intelligence quotient; HIV, human immunodeficiency virus; PCP, phencyclidine; LSD, lysergic acid diethylamide; alc, alcohol; nic/tob, nicotine/tobacco; marij, marijuana; cig, cigarette(s); AA, absolute alcohol; distrib, distribution; educ, education; soc/ec, socioeconomic. Dashes (−) indicate that no data were presented or the measure was not investigated. It should be noted that in the case of a discrepancy between the text of a reviewed article and the presented tables, we relied on the data in the (supplementary) tables.
Special characteristics or exclusion criteria of the study groups are given in parentheses.
Age at scanning, in the indicated units. Data are presented as mean ± SD.
Gestational age at birth, in weeks. Data are presented as mean ± SD.
Chead is the head circumference. Values are at birth unless otherwise noted. Data are presented as mean ± SD.
Age at delivery, in years. Data are presented as mean ± SD.
Years of education. Data are presented as mean ± SD.
Depression, as measured by the indicated scale.
Age at first scan.
Age at second scan.
Overview of the Reviewed Articles: Imaging Method, Between-Groups Brain Imaging Findings, and Associations with Cognitive and Behavioral Findingsa
| author | field strength (T) | method of analysis/toolbox | main findings | cognitive and behavioral characteristics of MA-exposed children relative to unexposed participants |
|---|---|---|---|---|
| Structural MRI Studies | ||||
| Chang
et al.,
2004[ | 1.5 | morphometry/DEC-ALPHA | smaller bilateral putamen, globus pallidus, and hippocampus | poorer performance on the visual-motor integration task |
| association between worse delayed verbal memory and smaller putamen and globus pallidus and between worse visual-motor integration score and smaller globus pallidus | worse performance on the sustained attention test | |||
| significantly poorer long delay verbal memory and long delay spatial memory | ||||
| Sowell et al., 2010[ | 1.5 | tensor-based morphometry | smaller volumes of bilateral subcortical thalamic and striatal regions and larger volumes of limbic cortices | decreased full scale intelligence quotient |
| Derauf et al.,
2012[ | 3 | morphometry/FreeSurfer | smaller caudate | increased (worse) HRT by ISI scores in cognition evaluation tests |
| no difference in cortical thickness | ||||
| correlation between MA-exposure status, mean caudate volume, and HRT by ISI scores | ||||
| Roos et al.,
2014[ | 3 | morphometry/FreeSurfer | increased left putamen volume | –/– |
| reduced left cortical thickness of the inferior parietal, parsopercularis, and precuneus areas | ||||
| gender effects | ||||
| boys: increased globus pallidus and bilateral diencephalon | ||||
| girls: decreased midposterior corpus callosum | ||||
| Warton et al.,
2018[ | 3 | morphometry/FreeSurfer | correlation between MA exposure and less right caudate volume and decreased left caudate and bilateral thalamus volumes at a trend level | –/– |
| Roos et al.,
2020[ | 3 | graph analysis/FreeSurfer | no significant between-group difference in normalized characteristic path length and clustering coefficient left superior parietal region and striatal hubs had increased connectivity changes over time in the MA-exposed group | –/– |
| similar patterns of change were observed in network connectivity on a regional level between groups | ||||
| MA-exposed group had significantly less change in modularity and transitivity compared to the control group (segregation parameters) | ||||
| network resilience as a measure of the minimum number of hubs needed to retain network integrity was not different between groups on a global or local level | ||||
| decreased cortical thickness in left precentral region, right caudal middle frontal, and right rostral anterior cingulate and increased cortical thickness in left superior parietal region | ||||
| decreased volume in left amygdala and increased volume in right putamen | ||||
| DTI Studies | ||||
| Cloak et al., 2009[ | 3 | DTIStudio | decreased ADC in right frontal and bilateral parietal WM A trend for increased FA in the left frontal WM | –/– |
| Colby
et al.,
2012[ | 1.5 | TBSS/FSL | increased FA in the genu of corpus callosum, left hemisphere internal and external capsule and corona radiata | decreased visual-motor integration score |
| decreased MD and RD but increased AD in the lateral corona radiata | decreased IQ | |||
| Roos et al.,
2015[ | 3 | TBSS/FSL | fecreased FA and increased MD and RD in the tracts that crossed the striatal, limbic, and frontal regions | poorer performance on motor coordination and executive function tests |
| correlation between decreased FA and poorer motor coordination | ||||
| Chang et al.,
2016[ | 3 | DtiStudio | in the superior corona radiata | decreased active muscle tone |
| boys: decreased age-dependent changes of FA and increased diffusivity (MD, AD, and RD) at earlier postmenstrual age with sharper declines later | ||||
| girls: no differences | ||||
| in the posterior corona radiata | ||||
| boys: increased diffusivity (MD, AD, and RD) at earlier postmenstrual age with sharper declines | ||||
| girls: no differences | ||||
| in the anterior corona radiata | ||||
| boys: no differences | ||||
| girls: decreased age-dependent changes of FA across time | ||||
| Warton et al.,
2018[ | 3 | tractography/AFNI | decreased FA in 3 WM connection: midbrain-left putamen, right putamen-right orbitofrontal cortex, and right putamen-right amygdala | –/– |
| increased RD in midbrain-right caudate | ||||
| Warton et al.
2020[ | 3 | probabilistic tractography/AFNI | negative association between MA exposure and FA in several WM connections in all five networks (commissural, left and right association, and left and right projection) | no difference in neonatal behavioral assessment scale |
| positive association between MA exposure and RD in several WM connections in all five networks (commissural, left and right association, and left and right projection) | ||||
| MRS Studies | ||||
| Smith
et al.,
2001[ | 1.5 | localized 1H-MRS/SPARC 2 workstation | increased total creatine in the striatum | social problems in 17%, aggressive behavior and anxious profile in 8% of MA-exposed children but no differences to unexposed participants |
| a trend for decreased [NA/Cr] in the frontal WM | ||||
| Chang et al.,
2009[ | 3 | localized 1H-MRS/LCModel program | frontal WM: increased total creatine, N-acetyl compounds, and glutamate + glutamine but decreased myoinositol/total creatine | decreased performance on Beery-Visual Motor Integration |
| thalamus: decreased myoinositol | ||||
| decreased thalamic myoinositol was associated with poorer performance on the Beery-Visual Motor Integration | ||||
| integration scores in both groups of children | ||||
| increased frontal white matter CHO was associated with poorer performance on the Expressive One Word Picture Vocabulary test scores in all children | ||||
| fMRI Studies | ||||
| Lu
et al.,
2009[ | 3 | BOLD/FSL | during the verbal memory task | decreased Full-Scale IQ |
| increased activation in bilateral medial temporal, bilateral basal ganglia, and right occipito-temporal regions | decreased performance on California Verbal Learning Test | |||
| lateralized activation of the left medial temporal region only in control group, which correlated to better performance | ||||
| Roussotte
et
al., 2011[ | 3 | BOLD/FSL | during the visuospatial working memory task | decreased performance on the Visuospatial working memory task |
| decreased activation in the frontal and basal ganglia regions in the left hemisphere | decreased full scale intelligence quotient | |||
| especially in the MA-exposed group, performance was negatively correlated to the activation in the left parahippocampal gyrus, bilateral pre- and postcentral gyri, superior temporal gyrus, and putamen | ||||
| Roussotte et
al., 2012[ | 3 | seed-based functional connectivity analysis/FSL | decreased correlation between activity caudate seeds and prefrontal regions | decreased performance on the Visuospatial working memory task |
| reduced functional connectivity between the dorsal caudate and frontal executive network | decreased full scale intelligence quotient | |||
| increased functional connectivity between the posterior putamen and the frontal executive network | ||||
Abbreviations: MA, methamphetamine; MRI, magnetic resonance imaging; DTI, diffusion tensor imaging; MRS, magnetic resonance imaging; fMRI, functional MRI; HRT, hit response time; ISI, interstimulus interval; TBSS, tract-based spatial statistics; WM, white matter; FA, fractional anisotropy; MD, mean diffusivity; AD, axial diffusivity; RD, radial diffusivity; BOLD, blood-oxygen level-dependent.
Figure 2Illustration showing the most affected cortical regions in prenatal methamphetamine (MA) exposure. Each arrow represents a separate study. Upward blue arrow: increased volume/thickness; downward blue arrow: decreased volume/thickness; upward red arrow: increased microstructural integrity; downward red arrow: decreased microstructural integrity; green arrow: altered metabolite concentration; upward yellow arrow: increased functional activity/connectivity; downward yellow arrow: decreased functional activity/connectivity.
Figure 3Illustration showing the most affected subcortical structures in prenatal methamphetamine (MA) exposure. Each arrow represents a separate study. Upward blue arrow: increased volume/thickness; downward blue arrow: decreased volume/thickness; upward red arrow: increased microstructural integrity; downward red arrow: decreased microstructural integrity; green arrow: altered metabolite concentration; upward yellow arrow: increased functional activity/connectivity; downward yellow arrow: decreased functional activity/connectivity.
Figure 4Illustration showing the underlying molecular mechanisms through which methamphetamine (MA) might affect brain structure and function.